galactitol has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuzy, M; Lelieveld, P; Van Putten, LM | 1 |
| Csuka, O; Gál, F; Institóris, L; Kellner, B; Németh, L; Pályi, I; Somfai, S; Sugár, J; Szentirmay, Z | 1 |
| Hansen, HH; Keyes, JW; Selawry, OS | 1 |
1 trial(s) available for galactitol and Leukemia L 1210
| Article | Year |
|---|---|
Initial clinical trial of dibromodulcitol (NSC-104800) in patients with advanced cancer.
Topics: Adult; Aged; Alkylating Agents; Animals; Blood Platelets; Bone Marrow; Bromine; Carcinoma, Squamous Cell; Clinical Trials as Topic; Dogs; Drug Tolerance; Evaluation Studies as Topic; Galactitol; Haplorhini; Hodgkin Disease; Humans; Leukemia L1210; Leukopenia; Male; Middle Aged; Neoplasms; Sugar Alcohols; Thrombocytopenia | 1971 |
2 other study(ies) available for galactitol and Leukemia L 1210
| Article | Year |
|---|---|
The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcoma.
Topics: Animals; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Ethers, Cyclic; Female; Galactitol; Hematopoietic Stem Cells; Injections, Intravenous; Lethal Dose 50; Leukemia L1210; Male; Mannitol; Mesylates; Mice; Mice, Inbred Strains; Mitobronitol; Mitolactol; Mustard Compounds; Osteosarcoma; Radiation Chimera; Sugar Alcohols | 1975 |
Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313).
Topics: Animals; Antineoplastic Agents; Cell Survival; Ethers, Cyclic; Galactitol; HeLa Cells; Lethal Dose 50; Leukemia L1210; Mice; Mitosis; Neoplasms, Experimental; Phagocytosis; Rabbits; Rats; Sugar Alcohols; Time Factors | 1972 |